Class in Session: DLL3 as a Therapeutic Target in Small-Cell Lung Cancer

Download slides, review a text module, and read an expert commentary on the rationale and clinical development of therapies targeting DLL3 for patients with small-cell lung cancer

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

This activity is supported by educational funding provided by

Amgen